Magnani John L. 4
4 · GLYCOMIMETICS INC · Filed Jan 22, 2021
Insider Transaction Report
Form 4
Magnani John L.
DirectorVP of Research, CSO
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-20+69,000→ 69,000 totalExercise: $3.81Exp: 2031-01-19→ Common Stock (69,000 underlying) - Award
Common Stock
2021-01-20+34,500→ 324,260 total
Holdings
- 4,845(indirect: By GlycoTech Corporation)
Common Stock
Footnotes (4)
- [F1]The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]25% of these restricted stock units vest on each of January 20, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service as of each such vesting date.
- [F3]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
- [F4]25% of the shares underlying this option vest on January 20, 2022 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.